MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MEOBF
  4. News
MEOBF
Quote
Short
News
Articles
Message Board

Mesoblast Ltd Ord (OTCMKTS : MEOBF ) News

Mesoblast Ltd Ord (OTCMKTS: MEOBF) News Releases

MEOBF News Releases
MEOBF : OTC
SeekingAlpha
Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
MEOBF : OTC
GlobeNewswire
Ryoncil® Profits Underpinning Substantial Growth Pipeline
MEOBF : OTC
GlobeNewswire
High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
MEOBF : OTC
GlobeNewswire
Ryoncil® Net Revenues Increase for the Quarter to US$30M
MEOBF : OTC
GlobeNewswire
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
MEOBF : OTC
GlobeNewswire
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
MEOBF : OTC
GlobeNewswire
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
MEOBF : OTC
GlobeNewswire
Mesoblast Announces Changes to Board of Directors' Leadership Roles
MEOBF : OTC
GlobeNewswire
Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
MEOBF : OTC
GlobeNewswire
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.